Veradermics Incorporated MANE on Wednesday released topline results from an open-label Phase 2 trial evaluating its ...

This is the second positive Phase II readout of VDPHL01, which analysts note could represent a $2bn+ market opportunity ...

Veradermics (MANE) stock jumps as a mid-stage trial for the company's lead drug, VDPHL01, in patients with female pattern ...

Hair loss remains an area lacking biotechnology innovation. The drugs currently available are older products offering limited efficacy. Some of them cannot be used by women. Veradermics aims to shake ...

Nearly two years after clinical setbacks cratered Q32’s stock price, new results showed hair growth improvements that ...

The biotech's Phase 2a study of bempikibart showed a 35.3% mean reduction in hair loss scores, with the company planning a ...

Hair loss has been at the forefront of everyone's mind since COVID-19. Scalp serums, hair supplements, hair-growth shampoos, massage tools, LED devices—the industry is booming. But what hasn't ...

For hundreds of years, people have dealt with receding hairlines and thin hair issues. With multiple haircare products, home remedies, and advanced treatments, a new scientific breakthrough could ...

New findings show hair loss affecting more young people in APACSocial media is driving earlier awareness of hair lossREGAINE® reaffirms commitment to research and innovation to meet evolving hair loss ...